retatrutide 2025 Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In Today's TRIUMPH-4 results are a

Participants who tasted more saltiness were more than twice as likely to say they felt satisfied after eating compared to those whose sense of saltiness didnt change

GLP-1 receptor agonists are a scientific breakthrough in weight management

Consistency with injections and adherence to any additional recommendations can help expedite your progress

They evaluate the manufacturers knowledge of the risks associated with its medication, its communications with the FDA, and the adequacy of its warning labels

They copy a natural hormone in your body called GLP1, which is made in the gut after you eat

Prevention is straightforward but requires discipline